Assertio Drug Patent Portfolio

Assertio owns 2 orange book drugs protected by 14 US patents Given below is the list of Assertio's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7662858 Method of treating post-surgical acute pain 24 Feb, 2029
Active
US7884095 Method of treating post-surgical acute pain 24 Feb, 2029
Active
US7939518 Method of treating post-surgical acute pain 24 Feb, 2029
Active
US8110606 Method of treating post-surgical acute pain 24 Feb, 2029
Active
US8623920 Method of treating post-surgical acute pain 24 Feb, 2029
Active
US9561200 Method of treating post-surgical acute pain 24 Feb, 2029
Active
US7759394 Diclofenac formulations and methods of use 16 Jun, 2026
Active
US8097651 Diclofenac formulations and methods of use 16 Jun, 2026
Active
US8927604 Diclofenac formulations and methods of use 16 Jun, 2026
Active
US9827197 Diclofenac formulations and methods of use 16 Jun, 2026
Active
US6365180 Oral liquid compositions 15 Jul, 2019 Expired
US6287594 Oral liquid compositions 15 Jan, 2019 Expired
US6974595 Pharmaceutical compositions based on Diclofenae 15 May, 2017 Expired
US7482377 Pharmaceutical compositions and methods of treatment based on diclofenac 15 May, 2017 Expired


Given below is the list of recent legal activities going on the following drug patents of Assertio.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 12th Year, Large Entity 07 Aug, 2023 US8110606
Payment of Maintenance Fee, 12th Year, Large Entity 17 Jul, 2023 US8097651
Payment of Maintenance Fee, 12th Year, Large Entity 10 Nov, 2022 US7939518
Payment of Maintenance Fee, 12th Year, Large Entity 08 Aug, 2022 US7884095
Payment of Maintenance Fee, 8th Yr, Small Entity 06 Jul, 2022 US8927604
Payment of Maintenance Fee, 12th Yr, Small Entity 20 Jan, 2022 US7759394
Email Notification 19 Jan, 2022 US9827197
Change in Power of Attorney (May Include Associate POA) 19 Jan, 2022 US9827197
Change in Power of Attorney (May Include Associate POA) 19 Jan, 2022 US8927604
Email Notification 19 Jan, 2022 US8927604
Correspondence Address Change 18 Jan, 2022 US9827197
Correspondence Address Change 18 Jan, 2022 US8927604
Payment of Maintenance Fee, 12th Year, Large Entity 16 Aug, 2021 US7662858
Payment of Maintenance Fee, 4th Yr, Small Entity 28 May, 2021 US9827197
Expire Patent 01 Mar, 2021 US7482377


Assertio's Family Patents

Assertio drugs have patent protection in a total of 23 countries. It's US patent count contributes only to 35.4% of its total global patent coverage. 6 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Assertio Drug List

Given below is the complete list of Assertio's drugs and the patents protecting them.


1. Cambia

Cambia is protected by 6 patents, out of which 2 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7759394 Diclofenac formulations and methods of use 16 Jun, 2026
(1 year, 6 months from now)
Active
US8097651 Diclofenac formulations and methods of use 16 Jun, 2026
(1 year, 6 months from now)
Active
US8927604 Diclofenac formulations and methods of use 16 Jun, 2026
(1 year, 6 months from now)
Active
US9827197 Diclofenac formulations and methods of use 16 Jun, 2026
(1 year, 6 months from now)
Active
US6974595 Pharmaceutical compositions based on Diclofenae 15 May, 2017
(7 years ago)
Expired
US7482377 Pharmaceutical compositions and methods of treatment based on diclofenac 15 May, 2017
(7 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Cambia's drug page


2. Zipsor

Zipsor is protected by 8 patents, out of which 2 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7662858 Method of treating post-surgical acute pain 24 Feb, 2029
(4 years from now)
Active
US7884095 Method of treating post-surgical acute pain 24 Feb, 2029
(4 years from now)
Active
US7939518 Method of treating post-surgical acute pain 24 Feb, 2029
(4 years from now)
Active
US8110606 Method of treating post-surgical acute pain 24 Feb, 2029
(4 years from now)
Active
US8623920 Method of treating post-surgical acute pain 24 Feb, 2029
(4 years from now)
Active
US9561200 Method of treating post-surgical acute pain 24 Feb, 2029
(4 years from now)
Active
US6365180 Oral liquid compositions 15 Jul, 2019
(5 years ago)
Expired
US6287594 Oral liquid compositions 15 Jan, 2019
(5 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zipsor's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List